VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $122,000 | +159.6% | 5,248 | +78.6% | 0.01% | +133.3% |
| Q1 2018 | $47,000 | -81.8% | 2,939 | -83.7% | 0.01% | -82.4% |
| Q3 2017 | $258,000 | +3125.0% | 17,994 | +5369.3% | 0.03% | +3300.0% |
| Q3 2016 | $8,000 | +166.7% | 329 | +92.4% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 171 | +87.9% | 0.00% | – |
| Q1 2016 | $2,000 | -71.4% | 91 | +28.2% | 0.00% | -100.0% |
| Q4 2015 | $7,000 | -70.8% | 71 | -47.8% | 0.00% | -80.0% |
| Q3 2015 | $24,000 | +9.1% | 136 | +34.7% | 0.01% | 0.0% |
| Q2 2015 | $22,000 | +175.0% | 101 | +165.8% | 0.01% | +150.0% |
| Q1 2015 | $8,000 | +100.0% | 38 | +8.6% | 0.00% | +100.0% |
| Q2 2014 | $4,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |